Daiwa Securities Group Inc. Sells 5,300 Shares of National Research Co. (NASDAQ:NRC)

Daiwa Securities Group Inc. decreased its holdings in National Research Co. (NASDAQ:NRC) by 13.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 34,318 shares of the company’s stock after selling 5,300 shares during the period. Daiwa Securities Group Inc.’s holdings in National Research were worth $1,358,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. iA Global Asset Management Inc. acquired a new position in shares of National Research in the 3rd quarter valued at about $11,124,000. Comerica Bank bought a new stake in National Research during the 3rd quarter worth approximately $6,939,000. Conestoga Capital Advisors LLC grew its holdings in shares of National Research by 6.0% in the third quarter. Conestoga Capital Advisors LLC now owns 773,215 shares of the company’s stock valued at $34,308,000 after acquiring an additional 43,475 shares in the last quarter. Skandinaviska Enskilda Banken AB publ grew its holdings in shares of National Research by 114.3% in the third quarter. Skandinaviska Enskilda Banken AB publ now owns 21,000 shares of the company’s stock valued at $932,000 after acquiring an additional 11,200 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of National Research by 1.1% in the third quarter. Vanguard Group Inc. now owns 980,693 shares of the company’s stock valued at $43,513,000 after acquiring an additional 10,454 shares in the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Stock Up 1.6 %

NRC opened at $34.24 on Wednesday. The business’s fifty day simple moving average is $38.46 and its 200 day simple moving average is $39.96. National Research Co. has a 52 week low of $32.08 and a 52 week high of $47.25. The stock has a market cap of $816.62 million, a PE ratio of 27.39 and a beta of 0.42. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.60.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, February 13th. The company reported $0.36 EPS for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%. The business had revenue of $38.00 million during the quarter.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.40%. The ex-dividend date of this dividend was Wednesday, March 27th. National Research’s dividend payout ratio (DPR) is currently 38.40%.

Analysts Set New Price Targets

Separately, TheStreet downgraded National Research from a “b-” rating to a “c+” rating in a research report on Thursday, January 11th.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.